IL6 and autoimmune thyroid disease: Moreover, IBT may result in autoimmune thyroiditis by enhancing the activity of lymphocytes, macrophages, and natural killer cells (23, 27–29); activating neutrophils and lymphocytes (20); inducing the release of IL-6 (23); and decreasing T-regulatory cell function by affecting the production of immunoglobulin (30, 31).